药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zuclopenthixol
Fontolizumab
The risk or severity of adverse effects can be increased when Fontolizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Matuzumab
The risk or severity of adverse effects can be increased when Matuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Labetuzumab
The risk or severity of adverse effects can be increased when Labetuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Adecatumumab
The risk or severity of adverse effects can be increased when Adecatumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
IGN311
The risk or severity of adverse effects can be increased when IGN311 is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Oregovomab
The risk or severity of adverse effects can be increased when Oregovomab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Bectumomab
The risk or severity of adverse effects can be increased when Bectumomab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Epratuzumab
The risk or severity of adverse effects can be increased when Epratuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Afelimomab
The risk or severity of adverse effects can be increased when Afelimomab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Pexelizumab
The risk or severity of adverse effects can be increased when Pexelizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Galiximab
The risk or severity of adverse effects can be increased when Galiximab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Formononetin
Formononetin may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Biochanin A
Biochanin A may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Moxestrol
Moxestrol may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Epimestrol
Epimestrol may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Methallenestril
Methallenestril may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Promestriene
Promestriene may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Equol
Equol may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Zeranol
Zeranol may increase the thrombogenic activities of Trastuzumab deruxtecan.
Zuclopenthixol
Esterified estrogens
Esterified estrogens may increase the thrombogenic activities of Trastuzumab deruxtecan.